Thomas Powles, Michiel Simon Van Der Heijden, Yohann Loriot, Jens Bedke, Begoña P. Valderrama, Gopa Iyer, Eiji Kikuchi, Jeannie Hoffman-Censits, Christof Vulsteke, Alexandra Drakaki, Steffen Rausch, Waddah Arafat, Se Hoon Park, Umang Swami, Jian-Ri Li, Seema Rao Gorla, Blanca Homet Moreno, Xuesong Yu, Yi-Tsung Lu, Shilpa Gupta. "EV-302: Updated analysis from the phase 3 global study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.664